SHOP APOTHEKE EUROPE NV (SAE.DE) Stock Fundamental Analysis

FRA:SAE • NL0012044747

88.3 EUR
-0.58 (-0.65%)
Last: Jun 12, 2023, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to SAE. SAE was compared to 26 industry peers in the Consumer Staples Distribution & Retail industry. While SAE seems to be doing ok healthwise, there are quite some concerns on its profitability. SAE is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • SAE had negative earnings in the past year.
  • In the past year SAE has reported a negative cash flow from operations.
SAE.DE Yearly Net Income VS EBIT VS OCF VS FCFSAE.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 0 -20M -40M -60M -80M

1.2 Ratios

  • SAE has negative profitability rations, so we won't be analyzing them here.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SAE.DE Yearly ROA, ROE, ROICSAE.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 -5 -10 -15 -20

1.3 Margins

  • The Gross Margin of SAE (27.83%) is better than 81.48% of its industry peers.
  • SAE's Gross Margin has improved in the last couple of years.
  • The Profit Margin and Operating Margin are not available for SAE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 27.83%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y11.94%
GM growth 5Y6.32%
SAE.DE Yearly Profit, Operating, Gross MarginsSAE.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 0 10 -10 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • SAE does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • SAE has more shares outstanding than it did 1 year ago.
  • SAE has a worse debt/assets ratio than last year.
SAE.DE Yearly Shares OutstandingSAE.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 5M 10M 15M
SAE.DE Yearly Total Debt VS Total AssetsSAE.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 200M 400M 600M

2.2 Solvency

  • SAE has an Altman-Z score of 3.78. This indicates that SAE is financially healthy and has little risk of bankruptcy at the moment.
  • SAE has a Altman-Z score of 3.78. This is amongst the best in the industry. SAE outperforms 81.48% of its industry peers.
  • SAE has a Debt/Equity ratio of 0.72. This is a neutral value indicating SAE is somewhat dependend on debt financing.
  • SAE's Debt to Equity ratio of 0.72 is fine compared to the rest of the industry. SAE outperforms 70.37% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.72
Debt/FCF N/A
Altman-Z 3.78
ROIC/WACCN/A
WACC6.74%
SAE.DE Yearly LT Debt VS Equity VS FCFSAE.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 0 100M 200M 300M 400M

2.3 Liquidity

  • A Current Ratio of 2.39 indicates that SAE has no problem at all paying its short term obligations.
  • The Current ratio of SAE (2.39) is better than 96.30% of its industry peers.
  • A Quick Ratio of 1.77 indicates that SAE should not have too much problems paying its short term obligations.
  • SAE has a better Quick ratio (1.77) than 96.30% of its industry peers.
Industry RankSector Rank
Current Ratio 2.39
Quick Ratio 1.77
SAE.DE Yearly Current Assets VS Current LiabilitesSAE.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. Growth

3.1 Past

  • SAE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 29.57%, which is quite impressive.
  • Looking at the last year, SAE shows a quite strong growth in Revenue. The Revenue has grown by 17.63% in the last year.
  • The Revenue has been growing by 33.50% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)29.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%56.74%
Revenue 1Y (TTM)17.63%
Revenue growth 3Y19.77%
Revenue growth 5Y33.5%
Sales Q2Q%22.07%

3.2 Future

  • Based on estimates for the next years, SAE will show a very strong growth in Earnings Per Share. The EPS will grow by 28.99% on average per year.
  • The Revenue is expected to grow by 24.47% on average over the next years. This is a very strong growth
EPS Next Y46.26%
EPS Next 2Y38.43%
EPS Next 3Y32.71%
EPS Next 5Y28.99%
Revenue Next Year21.52%
Revenue Next 2Y22.74%
Revenue Next 3Y22.49%
Revenue Next 5Y24.47%

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
SAE.DE Yearly Revenue VS EstimatesSAE.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B 4B
SAE.DE Yearly EPS VS EstimatesSAE.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 2 -2

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for SAE. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SAE. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SAE.DE Price Earnings VS Forward Price EarningsSAE.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100 -150 -200 -250

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SAE.DE Per share dataSAE.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

  • A more expensive valuation may be justified as SAE's earnings are expected to grow with 32.71% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y38.43%
EPS Next 3Y32.71%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for SAE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

SHOP APOTHEKE EUROPE NV

FRA:SAE (6/12/2023, 7:00:00 PM)

88.3

-0.58 (-0.65%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)N/A
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.63B
Revenue(TTM)1.27B
Net Income(TTM)-64.94M
Analysts73.33
Price Target95.37 (8.01%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)6.57%
PT rev (3m)22.38%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)18.02%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)3.7%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.28
P/FCF N/A
P/OCF N/A
P/B 4.68
P/tB 27.79
EV/EBITDA N/A
EPS(TTM)-3.57
EYN/A
EPS(NY)-0.33
Fwd EYN/A
FCF(TTM)-3.21
FCFYN/A
OCF(TTM)-0.49
OCFYN/A
SpS69.01
BVpS18.85
TBVpS3.18
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 27.83%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y11.94%
GM growth 5Y6.32%
F-Score3
Asset Turnover1.67
Health
Industry RankSector Rank
Debt/Equity 0.72
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 116.92%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.39
Quick Ratio 1.77
Altman-Z 3.78
F-Score3
WACC6.74%
ROIC/WACCN/A
Cap/Depr(3y)209.18%
Cap/Depr(5y)163.35%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)29.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%56.74%
EPS Next Y46.26%
EPS Next 2Y38.43%
EPS Next 3Y32.71%
EPS Next 5Y28.99%
Revenue 1Y (TTM)17.63%
Revenue growth 3Y19.77%
Revenue growth 5Y33.5%
Sales Q2Q%22.07%
Revenue Next Year21.52%
Revenue Next 2Y22.74%
Revenue Next 3Y22.49%
Revenue Next 5Y24.47%
EBIT growth 1Y7.26%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year130.3%
EBIT Next 3Y51.27%
EBIT Next 5Y41.47%
FCF growth 1Y-239.9%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-125.26%
OCF growth 3YN/A
OCF growth 5YN/A

SHOP APOTHEKE EUROPE NV / SAE.DE FAQ

Can you provide the ChartMill fundamental rating for SHOP APOTHEKE EUROPE NV?

ChartMill assigns a fundamental rating of 4 / 10 to SAE.DE.


What is the valuation status of SHOP APOTHEKE EUROPE NV (SAE.DE) stock?

ChartMill assigns a valuation rating of 1 / 10 to SHOP APOTHEKE EUROPE NV (SAE.DE). This can be considered as Overvalued.


How profitable is SHOP APOTHEKE EUROPE NV (SAE.DE) stock?

SHOP APOTHEKE EUROPE NV (SAE.DE) has a profitability rating of 1 / 10.


How financially healthy is SHOP APOTHEKE EUROPE NV?

The financial health rating of SHOP APOTHEKE EUROPE NV (SAE.DE) is 8 / 10.